corporate_fare

Instituto Grifols S.A.

Address
Calle De Can Guasch 2, Poligono Industrial Llevant

Sponsor Overview

assignment
1
sponsored trial
science
1
molecule
location_city
33
research centres
public
11
countries
person_search
33
investigators

Specializations

Hepatology and Acute-on-Chronic Liver Failure

Research activity is centered on cirrhosis complicated by acute-on-chronic liver failure, including patients identified with ACLF-1b, ACLF-2, and ACLF-3a during admission or hospitalization.

  • Liver failure
  • Cirrhosis
  • Hospital mortality

The sponsor’s clinical interest is focused on severe hepatic decompensation and outcomes in patients at high risk of death during acute liver deterioration.

Critical Care and Inpatient Survival

The funded trial addresses survival in hospitalized patients with advanced liver disease, reflecting interest in conditions managed within acute care and intensive monitoring settings.

  • Hospitalized patients
  • Severe systemic illness
  • Short-term survival

Clinical attention is directed toward outcomes measured over the 90-day period following acute deterioration in the setting of chronic liver disease.

Blood-Based Therapeutics and Plasma-Derived Treatment

The research portfolio includes evaluation of plasma-derived supportive treatment alongside standard medical care in severe liver disease.

  • Plasma therapy
  • Supportive treatment
  • Adjunctive care

This area links the sponsor’s clinical work to therapies used in liver support and management of complex inpatient complications.

Multinational Clinical Research

The sponsor is involved in a geographically distributed trial network spanning multiple countries and collaborating sites, with activity across Europe and other regions.

  • International recruitment
  • Collaborative sites
  • Cross-border study conduct

Its clinical research activity is concentrated in a single ongoing study with broad site participation for patients with advanced liver disease.

Sponsored Trials

Trial Name Country Status
Effects of Plasma Exchange with Human Serum Albumin 5% (PE-A 5%) on Short-term Survival in Subjects with Acute-On-Chronic Liver Failure" (ACLF) at High Risk of Hospital MortalityAustria AustriaBelgium BelgiumBulgaria BulgariaCroatia CroatiaFrance FranceGermany GermanyHungary HungaryItaly ItalyPoland PolandRomania RomaniaSpain SpainNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 1 total (0% not shared with other sponsors)

This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 33 sites collaborated multiple times

This sponsor has worked with 33 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Digestive System Diseases1 trial
    280 other sponsors

Partnered Research Centres

33 centres
location_city
assignment36
Acibadem City Clinic University Multiprofile Hospital For Active Treatment EOOD
Address
Konstantin Pomyanov Str 1, 1415 Sofia
Learn morearrow_forward
location_city
assignment413
ASST Grande Ospedale Metropolitano Niguarda
Address
Piazza Dell'ospedale Maggiore 3, 20162 Milan
Learn morearrow_forward
location_city
assignment392
Azienda Ospedaliera di Padova
Address
Via Nicolo' Giustiniani 2, 35128 Padua
Learn morearrow_forward
location_city
assignment41
Clinical Hospital Dubrava
Address
Avenija Gojka Suska 6, Zagreb, 10000 Zagreb
Learn morearrow_forward
location_city
assignment51
Clinical Medical Center Osijek
Address
Europska Avenija 14, 31000 Osijek
Learn morearrow_forward
location_city
assignment65
Emergency Institute For Cardiovascular Diseases And Transplant
Address
Strada Marinescu Gheorghe 50, 540136 Târgu Mureş
Learn morearrow_forward
Page 1 of 6

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Instituto Grifols S.A..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.